We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

78 hedge funds and large institutions have $402M invested in GenMark Diagnostics, Inc in 2014 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 35 increasing their positions, 21 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 21

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

0% more funds holding

Funds holding: 78 → 78 (0)

22% less capital invested

Capital invested by funds: $516M → $402M (-$114M)

Holders
78
Holders Change
–
Holders Change %
0%
% of All Funds
2.25%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
10
Increased
35
Reduced
21
Closed
8
Calls
$171K
Puts
–
Net Calls
+$171K
Net Calls Change
+$173K

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$10.3M
2
OM
Opaleye Management
Massachusetts
+$5.41M
3
Millennium Management
Millennium Management
New York
+$3.63M
4
Ameriprise
Ameriprise
Minnesota
+$3.13M
5
JHIU
Janus Henderson Investors US
Colorado
+$2.78M

Top Sellers

Rank Fund Capital Flow
1
PC
PointState Capital
New York
-$3.97M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$3.93M
3
MACM
March Altus Capital Management
Connecticut
-$2.98M
4
Artisan Partners
Artisan Partners
Wisconsin
-$2.92M
5
GTC
Ghost Tree Capital
New York
-$2.52M
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
51
BlackRock Advisors
Delaware
$264K +$28.4K +2,289 +9%
RhumbLine Advisers
52
RhumbLine Advisers
Massachusetts
$255K -$17.6K -1,420 -5%
AIG
53
American International Group
New York
$254K +$7.27K +585 +2%
PAAMCP
54
Pacific Alternative Asset Management Company (PAAMCO)
California
$242K +$303K +24,360 New
U
55
UBS
Switzerland
$234K -$634 -51 -0.2%
VOYA Investment Management
56
VOYA Investment Management
Georgia
$227K – – –
CS
57
Credit Suisse
Switzerland
$227K +$31K +2,492 +12%
AQR Capital Management
58
AQR Capital Management
Connecticut
$205K -$34.8K -2,800 -12%
GC
59
Guggenheim Capital
Illinois
$184K +$41K +3,299 +22%
Principal Financial Group
60
Principal Financial Group
Iowa
$180K -$1.01K -81 -0.4%
SCM
61
Sterling Capital Management
North Carolina
$153K +$191K +15,384 New
SCM
62
Stevens Capital Management
Pennsylvania
$132K +$165K +13,295 New
HighTower Advisors
63
HighTower Advisors
Illinois
$118K – – –
TAM
64
Telluride Asset Management
Minnesota
$109K +$137K +10,994 New
Wells Fargo
65
Wells Fargo
California
$102K +$23.6K +1,900 +23%
FAM
66
Fred Alger Management
New York
$87K +$2.61K +210 +2%
Citigroup
67
Citigroup
New York
$81K -$236K -18,992 -70%
TWA
68
TCI Wealth Advisors
Arizona
$60K – – –
MAA
69
Managed Account Advisors
New Jersey
$28K -$66.2K -5,328 -65%
Bank of Montreal
70
Bank of Montreal
Ontario, Canada
$20K – – –
TDC
71
Thompson Davis & Co
Virginia
$15K -$24.9K -2,000 -57%
Barclays
72
Barclays
United Kingdom
$13K -$6.57K -529 -27%
BlackRock
73
BlackRock
New York
$9K – – –
GT
74
Glenmede Trust
Pennsylvania
$9K – – –
Manulife (Manufacturers Life Insurance)
75
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4.75K +$456K +36,730 +8%
1 2
3
4

GNMK Hedge Fund Activity: Q1 2014 in Review

78 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q1 2014, worth a combined $402M — down 22% from $516M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new GNMK positions and 8 closed out — a net gain of 2 holders — while 35 added to existing stakes and 21 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $10.3M. The largest seller was PointState Capital, exiting entirely with an estimated $3.97M sold.

  • 78 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q1 2014, unchanged from Q4 2013.
  • Funds reported $402M of GenMark Diagnostics, Inc stock for Q1 2014, down 22% quarter-over-quarter.
  • 10 funds opened new GenMark Diagnostics, Inc positions in Q1 2014 and 8 closed out, a net change of +2 holders.
  • The largest GenMark Diagnostics, Inc buyer in Q1 2014 was JP Morgan Chase, an estimated $10.3M added.
  • The largest GenMark Diagnostics, Inc seller in Q1 2014 was PointState Capital, an estimated $3.97M sold.

Based on aggregated 13F filings for Q1 2014.